Data to be presented at the ASGCT Annual Meeting include an oral presentation from Sangamo’s flagship neurology epigenetic regulation program Nav1.7 to treat chronic neuropathic pain.

Inconsistencies in data presentation could harm efforts against COVID-19 New research shows broad array of different content, formats in data available on national public health institutes ...

Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021.

Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a ...

Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at ASCO 2025 and Investigator Meeting to Review Topline Data from the VIRAGE Phase 2b Trial of ...

Boston— Allarity Therapeutics, Inc., a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib— a differentiated dual PARP/Wnt pathway inhibitor— announced the ...

Perspective Therapeutics Announces Acceptance of Key Radiopharmaceutical Data for Presentation at ASCO 2025 Annual Meeting April 23, 2025 — 12:30 pm EDT Written by None for Quiver Quantitative -> ...

Dear Editor A FREQUENTLY used cautionary adage among competent analysts is that “Statistics don’t lie, liars use statistics.” Quite often, this adage also ...